CR2/CD21 proximal promoter activity is critically dependent on a cell type-specific repressor

被引:20
|
作者
Ulgiati, D
Holers, VM
机构
[1] Univ Colorado, Hlth Sci Ctr, Div Rheumatol, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80262 USA
[3] Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA
来源
JOURNAL OF IMMUNOLOGY | 2001年 / 167卷 / 12期
关键词
D O I
10.4049/jimmunol.167.12.6912
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Transcription of the human complement receptor type 2 (CR2/CD21) gene is controlled by both proximal promoter and intronic elements. CR2 is primarily expressed on B cells from the immature through mature cell stages. We have previously described the presence of an intronic element that is required for both cell- and stage-specific expression of CR2. In this study, we report the identification of a cell type-specific repressor element within the proximal promoter. This repressor sequence is shown by linker scanning mutagenesis to comprise an E box motif. By supershift analysis this element binds members of the basic helix-loop-helix family of proteins, in particular E2A gene products. Mutational analysis demonstrates that binding of E2A proteins is critical for functioning of this repressor. Thus, E2A activity is key not only for early B cell development, but also for controlling CR2 expression, a gene expressed only during later stages of ontogeny.
引用
收藏
页码:6912 / 6919
页数:8
相关论文
共 50 条
  • [41] Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists
    Kulik, Liudmila
    Chen, Kuan
    Huber, Brigitte T.
    Holers, V. Michael
    MOLECULAR IMMUNOLOGY, 2011, 48 (6-7) : 883 - 894
  • [42] High levels of human complement receptor 2 (CR2, CD21) expression in Cr2-/- mice results in a marked reduction in peripheral B cell numbers
    Marchbank, KJ
    Gibson, M
    Morgan, BP
    Holers, VM
    MOLECULAR IMMUNOLOGY, 2001, 38 (2-3) : 109 - 109
  • [43] Mouse complement receptors type 1 (CR1; CD35) and type 2 (CR2; CD21) - Expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice
    Takahashi, K
    Kozono, Y
    Waldschmidt, TJ
    Berthiaume, D
    Quigg, RJ
    Baron, A
    Holers, VM
    JOURNAL OF IMMUNOLOGY, 1997, 159 (03): : 1557 - 1569
  • [44] C3 regulates expression of human complement receptor 2 (CR2, CD21) on mouse B cells
    Marchbank, KJ
    Kulik, L
    Birrell, L
    Haluzcszak, C
    Holers, VM
    MOLECULAR IMMUNOLOGY, 2004, 41 (2-3) : 272 - 272
  • [45] Defective B cell ontogeny and immune response are partially reversed in aging human complement receptor 2 (CR2, CD21) transgenic mice
    Kulik, Liudmila
    Holers, V. Michael
    Marchbank, Kevin J.
    MOLECULAR IMMUNOLOGY, 2007, 44 (1-3) : 200 - 200
  • [46] The structural basis for complement receptor type 2 (CR2, CD21)-mediated alternative pathway activation of complement: studies with CR2 deletion mutants and vaccinia virus complement-control protein-CR2 chimeras
    Johnson, AA
    Rosengard, AM
    Skjodt, K
    Ahearn, JM
    Leslie, RGQ
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1999, 29 (12) : 3837 - 3844
  • [47] Decreased levels of serum soluble complement receptor-II (CR2/CD21) in patients with rheumatoid arthritis
    Masilamani, M
    von Kempis, J
    Illges, H
    RHEUMATOLOGY, 2004, 43 (02) : 186 - 190
  • [48] Cell-specific expression of the murine CD21 gene depends on accessibility of promoter and intronic elements
    Zabel, MD
    Byrne, BL
    Weis, JJ
    Weis, JH
    JOURNAL OF IMMUNOLOGY, 2000, 165 (08): : 4437 - 4445
  • [49] Expression of complement receptors 1 (CR1/CD35) and 2 (CR2/CD21), and co-signaling molecule CD19 in cattle
    Pringle, Eric S.
    Firth, Matthew A.
    Chattha, Kuldeep S.
    Hodgins, Douglas C.
    Shewen, Patricia E.
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2012, 38 (04): : 487 - 494
  • [50] Molecular Basis of the Interaction between Complement Receptor Type 2 (CR2/CD21) and Epstein-Barr Virus Glycoprotein gp350
    Young, Kendra A.
    Herbert, Andrew P.
    Barlow, Paul N.
    Holers, V. Michael
    Hannan, Jonathan P.
    JOURNAL OF VIROLOGY, 2008, 82 (22) : 11217 - 11227